J&J’s Earnings May Be Good News for Bristol-Myers Squibb and Medivation | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 18 October, 2015 by The TZ Newswire Staff

J&J’s Earnings May Be Good News for Bristol-Myers Squibb and Medivation

Slowing sales for two top-selling therapies may mean that competitors gained ground last month.

See also
- Next Article Oil Isn’t the Only Commodity That’s Crashing. What Does It Mean for Your Portfolio?
- Previous Article Chuck Jaffe: Keep finances healthy when confronting a serious medical issue
Editorial Calender

October 2015

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar